Study on Zika Vaccine Effects in Pregnant Mice

Background on Zika Virus and Birth Defects

Recent research has focused on the impacts of a Zika vaccine in pregnant mice and their offspring. In the United States, approximately ten percent of infants born to mothers infected with the Zika virus exhibit birth defects. The Zika virus, which is transmitted by mosquitoes, was first identified in primates during the 1940s. A prominent birth defect linked to the virus is microcephaly, characterized by an abnormally small brain in newborns.

Research Objectives and Methodology

While vaccines against the Zika virus have been developed, there has been limited research on the effects of administering a Zika vaccine to pregnant mothers. Key questions remain regarding the vaccine’s ability to protect the fetus, how pregnancy influences the mother’s immune response to the vaccine, and whether adjustments to vaccine dosage are necessary during pregnancy. To address these concerns, researchers from the University of Texas Medical Branch at Galveston conducted a study published in Nature Communications.

Findings on Vaccine Safety and Efficacy

The study evaluated the safety of the Zika vaccine when administered to pregnant mice at two different stages: early and midway through pregnancy. Results indicated that pups born to mice vaccinated early in their pregnancies did not exhibit Zika virus infection. Similarly, pups from mice vaccinated during the middle of their pregnancies also showed no signs of infection. However, the findings suggested that adequate time is essential for the mice to develop antibodies that can be transferred to their offspring.

Behavioral Observations of Offspring

Researchers also analyzed the behavior of the pups from vaccinated mice. The observed pups displayed normal growth patterns, as their body weight, body length, and behaviors were consistent with those of typical mouse pups.

Implications for Future Vaccine Development

The researchers concluded that the Zika vaccine is safe, with no adverse effects reported during the pregnancies. They noted that pregnancy appeared to weaken the immune response in the mice, indicating that either a higher dosage or a more potent vaccine may be necessary for effective protection during pregnancy. The study emphasizes the importance of continuing the development of Zika vaccines across various platforms to provide multiple preventative options against the virus. Additionally, the researchers highlighted significant differences in how humans transfer antibodies to their fetuses compared to mice.

References

Shan, C., Xie, X., Luo, H. et al. Maternal vaccination and protective immunity against Zika virus vertical transmission. Nat Commun 10, 5677 (2019) doi:10.1038/s41467-019-13589-1

Data & Statistics on Zika and Pregnancy | CDC. Centers for Disease Control and Prevention. https://www.cdc.gov/pregnancy/zika/data/index.html. Published 2019. Accessed December 14, 2019.

Image by mika mamy from Pixabay